Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension

NCT04707235 is registered in ClinicalTrials.gov with Theravia as lead sponsor.

NCT NCT04707235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Lead sponsor
Theravia
Phase
Observational
Overall status
Active, not recruiting
Start date
August 21, 2020
Completion date
August 21, 2025
Enrollment
2,093 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease